On March 30, 2026, IMAX Corporation announced that its Chief Executive Officer, Richard Gelfond, is on a temporary medical leave of absence due to treatment for pneumonia. The company has stated that Gelfond is receiving excellent care and is making progress in his recovery. During his absence, the senior executive team will manage day-to-day operations in coordination with Darren Throop, the Chair of the Board of Directors, ensuring regular communication with the full Board. This leadership change is expected to have a small negative impact on the company's operations and investor confidence, as Gelfond has been a key figure in the company's strategic direction and public representation. The company has reassured stakeholders that its operational plans are in place to maintain stability during this period. IMAX is committed to transparency and will provide updates regarding Gelfond's health as appropriate. The company emphasizes that it has a strong executive team in place to continue driving the business forward during this time.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.